帕金森病伴冲动控制障碍患者纹状体多巴胺转运体可用性及其代谢与临床相关性
本研究对比16例伴冲动控制障碍(ICD)与16例不伴ICD的帕金森病(PD)患者,用DaT SPECT评估纹状体多巴胺转运体(DaT)可用性,并用18F-FDG PET分析皮层代谢关联。结果发现PD-ICD患者腹侧纹状体DaT密度显著降低,且与ICD严重程度负相关;腹侧纹状体DaT降低与边缘及联合环路皮层FDG摄取降低相关,并与干扰/注意Stroop任务受损和焦虑相关。
要点
- PD伴ICD患者腹侧纹状体DaT密度较不伴ICD者显著降低,且与ICD严重程度负相关。
- 腹侧纹状体DaT降低与边缘及联合环路皮层FDG摄取降低相关(未校正p<0.0001,k>50体素)。
- PD-ICD患者干扰/注意Stroop任务受损和焦虑更明显,与腹侧纹状体和尾状核DaT降低相关。
核心结论
- PD患者的ICD与腹侧纹状体DaT结合降低相关,该降低反映涉及中脑边缘和中脑皮层系统的复杂皮层-皮层下网络功能障碍。
研究设计与样本
- 研究纳入16例伴ICD的PD患者(PD-ICD)和16例匹配的不伴ICD的PD患者(PD-noICD)。
- 使用DaT SPECT(DaTSCAN)评估预设纹状体感兴趣区(壳核、尾状核、腹侧纹状体)的DaT可用性。
- 在PD-ICD患者中,用18F-FDG PET和SPM8评估纹状体DaT结合与皮层边缘及联合代谢活动的关联。
- 评估DaT可用性与运动、行为和认知特征之间的关联。
主要发现
- PD-ICD患者腹侧纹状体DaT密度显著低于PD-noICD患者,且与ICD严重程度呈负相关。
- 腹侧纹状体DaT可用性降低与多个边缘和联合环路皮层区域及其他参与奖赏和抑制过程的区域FDG摄取降低相关(p<0.0001未校正;k>50体素)。
- 使用更严格的保守阈值(p<0.05;FDR校正)未观察到显著结果。
- PD-ICD患者表现出干扰和注意Stroop任务执行受损,以及更多焦虑,均与腹侧纹状体和尾状核DaT可用性降低相关。
关键数值与推荐
- 腹侧纹状体DaT密度降低与ICD严重程度呈负相关。
- 腹侧纹状体DaT降低与皮层FDG摄取降低的关联在未校正p<0.0001、k>50体素时显著,但FDR校正(p<0.05)后不显著。
临床怎么用
- 在PD患者中评估ICD时,可关注腹侧纹状体DaT可用性降低及相关的边缘/联合环路代谢改变。
- PD-ICD患者出现执行功能(如Stroop任务)受损和焦虑时,可能与腹侧纹状体和尾状核DaT降低相关。
局限性
- 皮层代谢与DaT关联的结果仅在未校正阈值下显著,FDR校正后无显著发现。
- 样本量较小(每组16例),结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous studies in patients with Parkinson's disease (PD) and impulse control disorders (ICDs) have produced heterogeneous results regarding striatal dopamine transporter (DaT) binding and activity in the mesocorticolimbic network. Our aim here was to study the relationship between striatal DaT availability and cortical metabolism, as well as motor, behavioural and cognitive features of PD patients with ICD. METHODS: In a group of PD patients with ICD (PD-ICD, n = 16) and 16 matched PD patients without ICD (PD-noICD, n = 16), DaT single-photon emission computed tomography (SPECT) imaging (DaTSCAN) was used to study DaT availability in predefined striatal volumes of interest (VOIs): putamen, caudate nucleus and ventral striatum (VS). In addition, the specific association of striatal DaT binding with cortical limbic and associative metabolic activity was evaluated by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in PD-ICD patients and investigated using statistical parametric mapping (SPM8). Finally, associations between DaT availability and motor, behavioural and cognitive features were assessed. RESULTS: PD-ICD patients had a significantly lower DaT density in the VS than PD-noICD patients, which was inversely associated with ICD severity. Lower DaT availability in the VS was associated with lower FDG uptake in several cortical areas belonging to the limbic and associative circuits, and in other regions involved in reward and inhibition processes (p < 0.0001 uncorrected; k > 50 voxels). No significant results were observed using a higher conservative threshold (p < 0.05; FDR corrected). PD-ICD patients also displayed impairment in interference and attentional Stroop Task execution, and more anxiety, all associated with reduced DaT availability in the VS and caudate nucleus. CONCLUSIONS: ICDs in PD patients are related to reduced DaT binding in the VS, which accounts for dysfunction in a complex cortico-subcortical network that involves areas of the mesolimbic and mesocortical systems, being associated with reward evaluation, salience attribution and inhibitory control processes.
引用
- Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, et al. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders. Eur J Nucl Med Mol Imaging. 2019. PMID: 31273436. doi:10.1007/s00259-019-04396-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。